NASDAQ · Medical - Specialties

CHRN (CHRN) Stock

$20.26 -5.77% NASDAQ: CHRN Healthcare

Valuation

MetricValue
Price$20.26
Market Cap$72.19M
P/E Ratio-3.90
P/B Ratio0.69
P/S Ratio32.48
EPS (TTM)$-4.91
52-Week High$29.63
52-Week Low$2.73
Dividend Yield—

Financials & Margins

MetricValue
ROE-133.33%
ROA-60.00%
ROCE-144.44%
Gross Margin-100.00%
Operating Margin-100.00%
Net Margin-86.20%
Debt/Equity1.71
Current Ratio1.56

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.0M$13.0M$18.0M$18.0M$13.0M
Operating Profit$-14.0M$-16.0M$-15.0M$-10.0M$-13.0M
Net Profit$-10.0M$-15.0M$-15.0M$-11.0M$-12.0M
EPS$-0.88$-1.16$-1.10$-8.43$-4.91
Op Margin-123.0%-120.0%-83.0%-58.0%-104.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$49.0M$41.0M$29.0M$27.0M$20.0M
Total Liabilities$12.0M$15.0M$16.0M$14.0M$11.0M
Cash$40.0M$21.0M$9.0M$4.0M$1.0M
Borrowings$2.0M$2.0M$2.0M$2.0M$2.0M

Latest News

Adeia Picks a Fight, and Investors Pick the Exit Trefis · Jul 3, 2026 ChronoScale (CHRN) Stock Valuation After Sharp 1 Year Surge And Rich P/S Multiple Simply Wall St. · Jun 13, 2026 Top Midday Gainers MT Newswires · Jun 4, 2026 ChronoScale Appoints Raj Jegannathan as Chief Technology Officer and Lawrence Lam as Chief Product Officer to Accelerate Global AI Infrastructure Strategy GlobeNewswire · Jun 4, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-15.0M$-12.0M$-10.0M$-12.0M
Investing Cash Flow$0$-5.0M$0$0$0
Financing Cash Flow$39.0M$0$0$8.0M$7.0M
Net Cash Flow$27.0M$-20.0M$-12.0M$-2.0M$-5.0M
Free Cash Flow$-11.0M$-15.0M$-12.0M$-10.0M$-12.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA9.39
FCF Yield-17.59%
Quick Ratio0.04
Interest Coverage—
Return 1Y694.88%
Return 3Y41.02%
Return 5Y-63.07%

Ownership

Insiders Held97.57%
Institutions Held1.19%
Institutions Float Held48.83%
Institutional HolderSharesReport Date
Hood River Capital Management LLC133,6362026-03-31
Mink Brook Asset Management LLC 95,3312026-03-31
Shay Capital LLC80,2502026-03-31
Vontobel Holding Limited52,9342026-03-31
Geode Capital Management, LLC43,5872026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About CHRN

CHRN is led by CEO Scott G. Davis, employs 55 people, headquartered in US, publicly traded since 2026.

CHRN stock trades at $20.26 with a market capitalization of $72.19M. The stock is valued at a price-to-earnings (P/E) ratio of -3.90, price-to-book of 0.69, price-to-sales of 32.48. Over the past 52 weeks the stock has ranged between $2.73 and $29.63, and currently trades 31.6% below its 52-week high.

On profitability, CHRN generates a return on equity (ROE) of -133.33%, return on capital employed of -144.44%, an operating margin of -100.00%, a net profit margin of -86.20%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides